<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>International Journal of Radiation Research</title>
<title_fa>نشریه پرتو پژوه</title_fa>
<short_title>Int J Radiat Res</short_title>
<subject>Basic Sciences</subject>
<web_url>http://ijrr.com</web_url>
<journal_hbi_system_id>79</journal_hbi_system_id>
<journal_hbi_system_user>journal79</journal_hbi_system_user>
<journal_id_issn>2322-3243</journal_id_issn>
<journal_id_issn_online>2345-4229</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.61882/ijrr</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1388</year>
	<month>12</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2010</year>
	<month>3</month>
	<day>1</day>
</pubdate>
<volume>7</volume>
<number>4</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Production of 177Lu and formulation of Ethylene diamine tetramethylene phosphonate (EDTMP) kits as a bone-seeking radiopharmaceutical</title>
	<subject_fa>Radiation Biology</subject_fa>
	<subject>Radiation Biology</subject>
	<content_type_fa>تحقيق بديع</content_type_fa>
	<content_type>Original Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>
&lt;span style=&quot;font-weight: bold&quot;&gt;Background:&lt;/span&gt; Owing to its favourable decay
characteristics 177Lu [T1/2= 6.71 d, Eβ(max)= 497
keV] is an attractive radionuclide for various
therapeutic applications. Ethylene diamine tatramethylene
phosphonate (EDTMP) is one of the most
widely used ligands which form stable complexes with
various radionuclides and all the complexes.
&lt;span style=&quot;font-weight: bold&quot;&gt;Materials and Methods:&lt;/span&gt; Enriched 176Lu2O3 was
dissolved in 0.1 N HCl and evaporated several times
and 176LuCl3 target was irradiated at 2.6×1013 n.Cm-
2.S-1 thermal neutron flux for 14 days.177LuCl3 was
dissolved in 1N HCl. EDTMP was dissolved in double
distilled water at pH=7.5-8.5 and freeze-dried kits
was radiolabeled with 177LuCl3. Distribution studies
were done in healthy mice. &lt;span style=&quot;font-weight: bold&quot;&gt;Results: &lt;/span&gt;The yield of 177Lu
was (~220 TBq/g 6000 Ci/g), the radionuclidic purity
was ~99%.The radiolabeling yield of EDTMP kits at
37°C after 30 min and 4 hours was 98±0.5% and
after 72 hours was 90±2.1%, the in vitro stability in
human serum at 37°C up to 72 hours post radiolabeling
was 85±1.8%.The biodistribution studies of
177Lu-EDTMP and 177LuCl3 in normal mice showed
skeleton uptake and low soft-tissue concentration.
&lt;span style=&quot;font-weight: bold&quot;&gt;Conclusion:&lt;/span&gt; In this study, we produce ~220 TBq/g
(6000 Ci/g) of 177Lu by neutron activation of 176Lu in
the Tehran Research Reactor. Our results showed
177Lu-EDTMP as a bone-seeking radiopharmaceutical.
Due to its suitable nuclear characteristics 177Lu
appears to be worthwhile for palliative therapy of
bone metastasis. Iran. J. Radiat. Res., 2010 7 (4): 229-234</abstract>
	<keyword_fa></keyword_fa>
	<keyword>DTMP, Bone-seeking radiopharmaceuticals, 177Lu.</keyword>
	<start_page>229</start_page>
	<end_page>234</end_page>
	<web_url>http://ijrr.com/browse.php?a_code=A-10-1-342&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>F.</first_name>
	<middle_name></middle_name>
	<last_name>Johari Daha</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>790031947532846001811</code>
	<orcid>790031947532846001811</orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>S.</first_name>
	<middle_name></middle_name>
	<last_name>Shafiei</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>790031947532846001922</code>
	<orcid>790031947532846001922</orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Sh.</first_name>
	<middle_name></middle_name>
	<last_name>Sheibani</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>790031947532846001923</code>
	<orcid>790031947532846001923</orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Y.H.</first_name>
	<middle_name></middle_name>
	<last_name>Tavakoli</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>790031947532846001924</code>
	<orcid>790031947532846001924</orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>M.</first_name>
	<middle_name></middle_name>
	<last_name>Mazidi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>790031947532846001925</code>
	<orcid>790031947532846001925</orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>M.H.</first_name>
	<middle_name></middle_name>
	<last_name>Mirfalah</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>790031947532846001926</code>
	<orcid>790031947532846001926</orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>M.H.</first_name>
	<middle_name></middle_name>
	<last_name>Babaei</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>mbabaei@aeoi.org.ir</email>
	<code>790031947532846001927</code>
	<orcid>790031947532846001927</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
